The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Primary age-related tauopathy (PART): a common pathology associated with human aging
Open accessAbstract
We recommend a new term, "primary age-related tauopathy" (PART), to describe a pathology that is commonly observed in the brains of aged individuals. Many autopsy studies have reported brains with neurofibrillary tangles (NFTs) that are indistinguishable from those of Alzheimer's disease (AD), in the absence of amyloid (Aβ) plaques. For these "NFT+/Aβ-" brains, for which formal criteria for AD neuropathologic changes are not met, the NFTs are mostly restricted to structures in the medial temporal lobe, basal forebrain, brainstem, and olfactory areas (bulb and cortex). Symptoms in persons with PART usually range from normal to amnestic cognitive changes, with only a minority exhibiting profound impairment. Because cognitive impairment is often mild, existing clinicopathologic designations, such as "tangle-only dementia" and "tangle-predominant senile dementia", are imprecise and not appropriate for most subjects. PART is almost universally detectable at autopsy among elderly individuals, yet this pathological process cannot be specifically identified pre-mortem at the present time. Improved biomarkers and tau imaging may enable diagnosis of PART in clinical settings in the future. Indeed, recent studies have identified a common biomarker profile consisting of temporal lobe atrophy and tauopathy without evidence of Aβ accumulation. For both researchers and clinicians, a revised nomenclature will raise awareness of this extremely common pathologic change while providing a conceptual foundation for future studies. Prior reports that have elucidated features of the pathologic entity we refer to as PART are discussed, and working neuropathological diagnostic criteria are proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Perivascular, subpial, and periventricular p-tau immunoreactive NFTs and astrocytic tangles in the neocortex have been reported to be characteristic of both primary age-related tauopathy (PART) [35] and age-related tau astrogliopathy (ARTAG) [36].”
From The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features (2017) · cites this paper as [35]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Primary age-related tauopathy (PART) and aging-related tau astrogliopathy (ARTAG) are independent tau pathologies commonly observed in patients over 80 years of age, and PART may account for a proportion of the misdiagnosed clinical AD cases in the elderly [130, 141, 142].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [142]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lesions are found in the hippocampus and adjacent regions similar to those observed in Braak I-IV, but PART is distinct from AD in that it lacks amyloid plaques, and it has distinct morbidity and age range [130, 142].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [142]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PART refers to neuronal tau pathology and ARTAG is characterized by astrocytic tau pathology, although they are not mutually exclusive, and appear to be more a manifestation of age than a subtype of neurodegenerative disease.”
From The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features (2017) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many studies, from the histopathology of Braak and Braak4 to longitudinal studies of Tau positron emission tomography imaging27,28, demonstrate that MTG is a transition zone between aging-related or preclinical AD-related medial temporal lobe pTau and more advanced stages of AD, where neocortical pTau extends across the brain and is strongly correlated with dementia4,29–31.”
From Integrated multimodal cell atlas of Alzheimer’s disease (2024) · cites this paper as [29]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It should be noted that tau aggregation in the brain is associated with older age and is generally uncommon in healthy young adults (Braak et al., 2011; Crary et al., 2014).”
From Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms (2022) · cites this paper as Crary et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“LATE and PART are common neuropathologies, indicating the importance of addressing potential relationships between AD-Mimics, and LATE and PART pathology in future research (20,22).”
From Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy (2020) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“AD-Mimics and definite PART are both defined as having no neuritic plaques, and like the AD-Mimics in this study, PART participants are generally older and experience less severe cognitive dysfunction (22,23).”
From Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy (2020) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“The compact NFTs observed are morphologically most like those seen in primary age-related tauopathy (PART) [4], Alzheimer’s disease (AD) [22], and chronic traumatic encephalopathy (CTE) [13, 14], but the topographical distribution and immunostaining characteristics differ from these more common tauopathies in several respects.”
From Tuberous sclerosis complex is associated with a novel human tauopathy (2023) · cites this paper as [4]
In the citing paper
“APOE4 significantly aggravated tau-mediated neurodegeneration in a tauopathy mouse model and induced tau aggregates in brain, while genetic ablation of APOE attenuated tau-induced neurodegeneration [469, 470].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [470]
In the citing paper
“In AD and PART, the tau aggregates are a mixture of three-repeat and four-repeat tau isoforms, whereas four-repeat sequences dominate in PSP and CBD and three-repeat sequences predominate in Pick disease14,18,19,21.”
From Tau-targeting therapies for Alzheimer disease (2018) · cites this paper as [14]
In the citing paper
“More recently, Crary et al. coined the term “primary age-related tauopathy” (PART) after observing that the postmortem brains of many elderly individuals harbor NFTs indistinguishable from those of AD but in the absence of Aβ plaques or cognitive decline [44].”
From Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau (2021) · cites this paper as [44]
In the citing paper
“The panel did not ultimately accept all of the a priori criteria for CTE; they did not include pathology known to be associated with aging (i.e.primary age-related tauopathy [PART] [16] and aging-related tau astrogliopathy [ARTAG] [17]).”
From Mild Chronic Traumatic Encephalopathy Neuropathology in People With No Known Participation in Contact Sports or History of Repetitive Neurotrauma (2019) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Self-citationNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Self-citationBraak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172
Self-citationHyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092
Self-citationMontine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894 · cited 3×
“the current guidelines for AD [64, 102], mild Aβ plaques”
BackgroundInfluentialSelf-citationConsortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
Staging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,002
A golden age of muscarinic acetylcholine receptor modulation in neurological diseases
Tobin, A. B. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01007-1 · Cited by 38
Dementia in the oldest old: Beyond Alzheimer disease
Pierce, A. L., & Kawas, C. H. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002263 · Cited by 38
Sala, I., Illán‐Gala, I., Alcolea, D. A., Sánchez‐Saudinós, M. B., Salgado, S. A., Morenas‐Rodríguez, E., Subirana, A., Videla, L., Clarimón, J., Carmona‐Iragui, M., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170073 · Cited by 38
Cognitive composite score association with Alzheimer’s disease plaque and tangle pathology
Malek‐Ahmadi, M. H., Chen, K., Perez, S. E., He, A., & Mufson, E. J. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0401-z · Cited by 38
Spectrum of tau pathologies in Huntington's disease
Baskota, S. U., López, O. L., Greenamyre, J. T., & Kofler, J. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0166-9 · Cited by 38
Self-citationWhite matter alterations in Alzheimer’s disease without concomitant pathologies
Ferrer, I., & Andrés‐Benito, P. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12618 · Cited by 38
Devous, M. D., Fleisher, A., Pontecorvo, M. J., Lu, M., Siderowf, A. D., Navitsky, M. A., Kennedy, I. A., Southekal, S. S., Harris, T. S., & Mintun, M. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200808 · Cited by 38
Inter-Subject Variability of Axonal Injury in Diffuse Traumatic Brain Injury
Ware, J. B., Hart, T., Whyte, J., Rabinowitz, A. R., Detre, J. A., & Kim, J. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2016.4817 · Cited by 38
ARTAG in the basal forebrain: widening the constellation of astrocytic tau pathology
Liu, A. K. L., Goldfinger, M., Questari, H. E., Pearce, R. K. B., & Gentleman, S. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0330-7 · Cited by 38
Pathology of neurodegenerative disease for the general neurologist
Cullinane, P. W., Wrigley, S., Parmera, J. B., Valério, F., Millner, T. O., Shaw, K., Pablo‐Fernández, E. D., Warner, T. T., & Jaunmuktane, Z. (2023) · Practical Neurology · doi:10.1136/pn-2023-003988 · Cited by 37
A biomarker study in long-lasting amnestic mild cognitive impairment
Cerami, C., Dodich, A., Iannaccone, S., Magnani, G., Santangelo, R., Presotto, L., Marcone, A., Gianolli, L., Cappa, S. F., & Perani, D. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0369-8 · Cited by 37
Relevance of host tau in tau seeding and spreading in tauopathies
Ferrer, I., Zelaya, M. V., Aguiló, M., Carmona, M., López‐González, I., Andrés‐Benito, P., Lidón, L., Gavı́n, R., Garcia‐Esparcia, P., & del Rı́o, J. A. (2019) · Brain Pathology · doi:10.1111/bpa.12778 · Cited by 37
Temporal trajectories of in vivo tau and amyloid-β accumulation in Alzheimer’s disease
Baek, M. S., Cho, H., Lee, H. S., Choi, J. Y., Lee, J., Ryu, Y. H., Lee, M. S., & Lyoo, C. H. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04773-3 · Cited by 37
Normal ageing of the brain: Histological and biological aspects
Teissier, T., Boulanger, É., & Deramecourt, V. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.03.017 · Cited by 37
What Is T+? A Gordian Knot of Tracers, Thresholds, and Topographies
Villemagne, V. L., Lopresti, B. J., Doré, V., Tudorascu, D., Ikonomović, M. D., Burnham, S. C., Minhas, D. S., Pascoal, T. A., Mason, N. S., Snitz, B. E., et al. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.245423 · Cited by 37
Pathological drivers of neurodegeneration in suspected non-Alzheimer’s disease pathophysiology
Wisse, L. E. M., de Florès, R., Xie, L., Das, S. R., McMillan, C. T., Trojanowski, J. Q., Grossman, M., Lee, E. B., Irwin, D. J., Yushkevich, P. A., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00835-2 · Cited by 37
Self-citationA History of Senile Plaques: From Alzheimer to Amyloid Imaging
Beach, T. G. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac030 · Cited by 37
Self-citationAssessing mild cognitive impairment using object‐location memory in immersive virtual environments
Castegnaro, A., Howett, D., Li, A., Harding, E. M., Chan, D., Burgess, N., & King, J. A. (2022) · Hippocampus · doi:10.1002/hipo.23458 · Cited by 37
Adams, J. N., Kim, S., Rizvi, B. M., Sathishkumar, M. T., Taylor, L., Harris, A. L., Mikhail, A., Keator, D. B., McMillan, L. C., & Yassa, M. A. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1165-22.2022 · Cited by 39
A 19-Year-Old Adolescent with Probable Alzheimer’s Disease1
Jia, J., Zhang, Y., Shi, Y., Yin, X., Wang, S., Li, Y., Zhao, T., Liu, W., Zhou, A., & Jia, L. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-221065 · Cited by 37
Hickman, L. B., Stern, J. M., Silverman, D. H. S., Salamon, N., & Vossel, K. A. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1241638 · Cited by 37
Gao, R., Ku, T., Ji, X., Zhang, Y., Li, G., & Sang, N. (2017) · Journal of Environmental Sciences · doi:10.1016/j.jes.2017.06.037 · Cited by 37
Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review
Pozzi, F. E., Conti, E., Appollonio, I., Ferrarese, C., & Tremolizzo, L. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.998224 · Cited by 36
Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration
Li, W., & Li, J. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00407-y · Cited by 37
Weller, R. O., Hawkes, C. A., Carare, R. O., & Hardy, J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1416-1 · Cited by 36
Pharmacological Modulators of Tau Aggregation and Spreading
Dominguez‐Meijide, A., Vasili, E., & Outeiro, T. F. (2020) · Brain Sciences · doi:10.3390/brainsci10110858 · Cited by 36
Gessi, S., Poloni, T. E., Negro, G., Varani, K., Pasquini, S., Vincenzi, F., Borea, P. A., & Merighi, S. (2021) · Cells · doi:10.3390/cells10092344 · Cited by 36
Genome-wide association study and functional validation implicates JADE1 in tauopathy
Farrell, K. W., Kim, S., Han, N., Iida, M. A., Gonzalez, E. M., Otero‐García, M., Walker, J. M., Richardson, T. E., Renton, A. E., Andrews, S. J., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02379-z · Cited by 36
Self-citationMertens, N., Michiels, L., Vanderlinden, G., Vandenbulcke, M., Lemmens, R., Laere, K. V., & Koole, M. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221076023 · Cited by 36
Walker, A. P., Chapin, B. A., Abisambra, J. F., & DeKosky, S. T. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01311-0 · Cited by 36
Self-citationA Machine Learning–Based Approach to Discrimination of Tauopathies Using [ 18F ] PM‐PBB3 PET Images
Endo, H., Tagai, K., Ono, M., Ikoma, Y., Oyama, A., Matsuoka, K., Kokubo, N., Hirata, K., Sano, Y., Oya, M., et al. (2022) · Movement Disorders · doi:10.1002/mds.29173 · Cited by 36
TDP-43 Proteinopathy and Tauopathy: Do They Have Pathomechanistic Links?
Riku, Y., Yoshida, M., Iwasaki, Y., Sobue, G., Katsuno, M., & Ishigaki, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415755 · Cited by 36
Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms
Hwang, K., Vaknalli, R. N., Addo-Osafo, K., Vicente, M., & Vossel, K. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.903973 · Cited by 35
Teylan, M., Besser, L. M., Crary, J. F., Mock, C., Gauthreaux, K., Thomas, N. M., Chen, Y.-C., & Kukull, W. A. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0186-0 · Cited by 35
Self-citationWalker, J. M., Goette, W. F., Farrell, K. W., Iida, M. A., Karlovich, E., The PART Working Group, White, C. L., Crary, J. F., & Richardson, T. E. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12966 · Cited by 35
Self-citationKhan, G., Hussain, M. S., Khan, Y., Fatima, R., Ahmad, S., Sultana, A., & Alam, P. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149776 · Cited by 35
Fletcher, E. M., Villeneuve, S., Maillard, P., Harvey, D. J., Reed, B., Jagust, W. J., & DeCarli, C. S. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.01.133 · Cited by 35
Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment
Louwersheimer, E., Wolfsgruber, S., Espinosa, A., Lacour, A., Heilmann‐Heimbach, S., Alegret, M., Hernández, I., Rosende‐Roca, M., Tárraga, L., Boada, M., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.01.006 · Cited by 35
Zhao, Y., Tudorascu, D., López, O. L., Cohen, A. D., Mathis, C. A., Aizenstein, H. J., Price, J. C., Kuller, L. H., Kamboh, M. I., DeKosky, S. T., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3029 · Cited by 35
Louis, E. D., Hernandez, D. I., Hernandez, N. C., Flowers, X. E., Kuo, S., Vonsattel, J. P., & Faust, P. L. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac068 · Cited by 35
Self-citationInterpretable deep learning of myelin histopathology in age-related cognitive impairment
McKenzie, A. T., Marx, G. A., Koenigsberg, D., Sawyer, M., Iida, M. A., Walker, J. M., Richardson, T. E., Campanella, G. S. V., Attems, J., McKee, A. C., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01425-5 · Cited by 36
Self-citationIn vivo coupling of tau pathology and cortical thinning in Alzheimer's disease
Mak, E., Bethlehem, R. A. I., Romero-García, R., Červenka, S., Rittman, T., Gabel, S., Surendranathan, A., Bevan-Jones, W. R., Passamonti, L., Rodríguez, P. V., et al. (2018) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.08.005 · Cited by 35
Parker, T. D., Cash, D. M., Lane, C., Lu, K., Malone, I. B., Nicholas, J. M., James, S., Keshavan, A., Murray‐Smith, H., Wong, A., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224030 · Cited by 35
Primary retinal tauopathy: A tauopathy with a distinct molecular pattern
Walkiewicz, G., Ronisz, A., Ginderdeuren, R. V., Lemmens, S., Bouwman, F. H., Hoozemans, J. J. M., Morrema, T. H. J., Rozemüller, A. J. M., de Ruyter, F. J. H., Groef, L. D., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13424 · Cited by 34
Self-citationSELF-REPORTED MEMORY COMPLAINTS: A COMPARISON OF DEMENTED AND UNIMPAIRED OUTCOMES
Kryscio, R. J., Abner, E. L., Jicha, G. A., Nelson, P. T., Smith, C. D., Eldik, L. J. V., Lou, W., Fardo, D. W., Cooper, G. E., & Schmitt, F. A. (2015) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2015.74 · Cited by 34
Self-citationHuuskonen, M. T., Loppi, S. H., Dhungana, H., Keksa-Goldsteine, V., Lemarchant, S., Korhonen, P., Wojciechowski, S., Pollari, E., Valonen, P. K., Koponen, J., et al. (2016) · Scientific Reports · doi:10.1038/srep33176 · Cited by 34
Mock, C., Teylan, M., Beecham, G. W., Besser, L. M., Cairns, N. J., Crary, J. F., Katsumata, Y., Nelson, P. T., & Kukull, W. A. (2020) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000380 · Cited by 34
Self-citationCentenarians as Models of Resistance and Resilience to Alzheimer’s Disease and Related Dementias
Andersen, S. L. (2020) · Advances in Geriatric Medicine and Research · doi:10.20900/agmr20200018 · Cited by 35
AD risk score for the early phases of disease based on unsupervised machine learning
Wang, Z., Tang, Z., Zhu, Y., Pettigrew, C. A., Soldan, A., Gross, A. L., & Albert, M. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12140 · Cited by 34
Expression of GFAP and Tau Following Blast Exposure in the Cerebral Cortex of Ferrets
Schwerin, S. C., Chatterjee, M., Hutchinson, E. B., Djankpa, F. T., Armstrong, R. C., McCabe, J. T., Perl, D. P., & Juliano, S. L. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa157 · Cited by 34
Laczó, M., Martinkovič, L., Lerch, O., Wiener, J. M., Kalinová, J., Matušková, V., Nedelská, Z., Vyhnálek, M., Hort, J., & Laczó, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.886778 · Cited by 34
APOE ε4 genotype, amyloid-β, and sex interact to predict tau in regions of high APOE mRNA expression
Dincer, A., Chen, C. D., McKay, N. S., Koenig, L. N., McCullough, A. A., Flores, S. E., Keefe, S., Schultz, S. A., Feldman, R. L., Joseph‐Mathurin, N., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl7646 · Cited by 34
Hanseeuw, B. J., Jacobs, H. I. L., Schultz, A. P., Buckley, R. F., Farrell, M. E., Guehl, N. J., Becker, J. A., Properzi, M. J., Sanchez, J. S., Quiroz, Y. T., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207962 · Cited by 34
Cykowski, M. D., Powell, S. Z., Schulz, P. E., Takei, H., Rivera, A. L., Jackson, R. E., Roman, G., Jicha, G. A., & Nelson, P. T. (2017) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2016-0469-sa · Cited by 33
Self-citationSchreiber, S., Schreiber, F., Lockhart, S. N., Horng, A., Bejanin, A., Landau, S. M., Jagust, W. J., & Initiative, A. D. N. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.5349 · Cited by 33
Primary Age-Related Tauopathy: An Elderly Brain Pathology Frequently Encountered during Autopsy
Kim, D., Kim, H.-S., Choi, S., Kim, B. C., Lee, M. C., Lee, K., & Lee, J.-H. (2019) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2019.03.14 · Cited by 34
Sex differences in in vivo tau neuropathology in a multiethnic sample of late middle-aged adults
Palta, P., Rippon, B., Tahmi, M., Pardo, M., Johnson, A. S., Tomljanovic, Z., He, H., Laing, K. K., Razlighi, Q. R., Teresi, J. A., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.03.007 · Cited by 33
Asymmetry of Hippocampal Tau Pathology in Primary Age-Related Tauopathy and Alzheimer Disease
Walker, J. M., Fudym, Y., Farrell, K. W., Iida, M. A., Bieniek, K. F., Seshadri, S. S., White, C. L., Crary, J. F., & Richardson, T. E. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab032 · Cited by 33
Self-citationThe correlation between neuropathology levels and cognitive performance in centenarians
Zhang, M., Ganz, A. B., Rohde, S. K., Lorenz, L. M. C., Rozemüller, A. J. M., van Vliet, K., Graat, M., Sikkes, S. A. M., Reinders, M. J. T., Scheltens, P., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13087 · Cited by 34
Neuropathologic analysis of Tyr69His TTR variant meningovascular amyloidosis with dementia
Ziskin, J. L., Greicius, M. D., Zhu, W., Okumu, A. N., Adams, C. M., & Plowey, E. D. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0216-0 · Cited by 33
Neuropathology of supercentenarians - four autopsy case studies
Takao, M., Hirose, N., Arai, Y., Mihara, B., & Mimura, M. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0368-6 · Cited by 33
Self-citationEvidence-based Interpretation of Amyloid-β PET Results
Bergeron, D., Ossenkoppele, R., & Laforce, R. J. (2018) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000239 · Cited by 33
Chen, X., Farrell, M. E., Rundle, M. M., Chan, M. Y., Moore, W., Wig, G. S., & Park, D. C. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.04.020 · Cited by 32
Freiburghaus, T., Pawlik, D., Hauer, K. O., Ossenkoppele, R., Strandberg, O. T., Leuzy, A., Rittmo, J. Ö., Tremblay, C., Serrano, G. E., Pontecorvo, M. J., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02801-2 · Cited by 34
Self-citationJiang, Y., Huang, H., Abner, E. L., Broster, L. S., Jicha, G. A., Schmitt, F. A., Kryscio, R. J., Andersen, A. H., Powell, D. K., Eldik, L. J. V., et al. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00015 · Cited by 32
Self-citationTau Filaments and the Development of Positron Emission Tomography Tracers
Goedert, M., Yamaguchi, Y., Mishra, S. K., Higuchi, M., & Sahara, N. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00070 · Cited by 32
Josephs, K. A., Murray, M. E., Tosakulwong, N., Weigand, S. D., Knopman, D. S., Petersen, R. C., Jack, C. R., Whitwell, J. L., & Dickson, D. W. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.03.003 · Cited by 32
Self-citationon behalf of the Cognitive Function and Ageing Neuropathology Study Group, Wharton, S. B., Wang, D. Y. Q., Parikh, C. R., Matthews, F. E., Brayne, C., & Ince, P. G. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0858-4 · Cited by 32
Ono, D., Dickson, D. W., & Koga, S. (2024) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12997 · Cited by 32
Self-citationYgland, E., van Westen, D., Englund, E. M., Rademakers, R., Wszołek, Z. K., Nilsson, K. H., Nilsson, C., Waldö, M. L., Alafuzoff, I. I., Hansson, O., et al. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0330-2 · Cited by 32
Self-citationComparison of Amyloid β and Tau Spread Models in Alzheimer’s Disease
Kim, H., Lee, P., Seo, S. W., Roh, J. H., Oh, M., Oh, J. S., Oh, S. J., Kim, J. S., & Jeong, Y. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy311 · Cited by 32
Alpha-Synuclein deficiency ameliorates chronic methamphetamine induced neurodegeneration in mice
Ding, J., Hu, S., Meng, Y., Li, C., Huang, J. A., He, Y., & Qiu, P. (2020) · Toxicology · doi:10.1016/j.tox.2020.152461 · Cited by 31
Arena, J. D., Johnson, V. E., Lee, E. B., Gibbons, G. S., Smith, D. H., Trojanowski, J. Q., & Stewart, W. B., Jr. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa210 · Cited by 31
Self-citationG protein‐coupled receptor kinases are associated with Alzheimer's disease pathology
Guimarães, T. R., Swanson, E., Kofler, J., & Thathiah, A. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12742 · Cited by 31
Self-citationShively, S. B., Priemer, D. S., Stein, M. B., & Perl, D. P. (2021) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2021.04.003 · Cited by 32
Smirnov, D. S., Salmon, D. P., Galasko, D. R., Goodwill, V., Hansen, L. A., Zhao, Y., Edland, S. D., Léger, G. C., Peavy, G. M., Jacobs, D. M., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000013107 · Cited by 31
Pająk, B., Kania, E., & Orzechowski, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1805304 · Cited by 31
Trends in autopsy‐verified dementia prevalence over 29 years of the Hisayama study
Honda, H., Sasaki, K., Hamasaki, H., Shijo, M., Koyama, S., Ohara, T., Ninomiya, T., Kiyohara, Y., Suzuki, S. O., & Iwaki, T. (2016) · Neuropathology · doi:10.1111/neup.12298 · Cited by 31
A quantitative study of tau pathology in 11 cases of chronic traumatic encephalopathy
Armstrong, R. A., McKee, A. C., Stein, T. D., Alvarez, V. E., & Cairns, N. J. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12323 · Cited by 31
Self-citationMixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series
Kim, E., Brown, J. A., Deng, J., Hwang, J., Spina, S., Miller, Z., DeMay, M. G., Valcour, V., Karydas, A., Ramos, E. M., et al. (2018) · Journal of Neurology · doi:10.1007/s00415-018-9086-2 · Cited by 32
Self-citationConcurrent tau pathologies in frontotemporal lobar degeneration with TDP‐43 pathology
Koga, S., Zhou, X., Murakami, A., Fernandez De Castro, C., Baker, M. C., Rademakers, R., & Dickson, D. W. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12778 · Cited by 30
Self-citationLiquid − liquid phase separation of tau: Driving forces, regulation, and biological implications
Li, P., Chen, J., Wang, X., Su, Z., Gao, M., & Huang, Y. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106167 · Cited by 30
Limbic-predominant age-related TDP-43 encephalopathy in the oldest old: a population-based study
Mikhailenko, E., Colangelo, K., Tuimala, J., Kero, M., Savola, S. E., Raunio, A., Kok, E., Tanskanen, M., Mäkelä, M., Puttonen, H. A. J., et al. (2024) · Brain · doi:10.1093/brain/awae212 · Cited by 30
Khan, A. F., & Iturria‐Medina, Y. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03073-w · Cited by 31
Anterior-temporal network hyperconnectivity is key to Alzheimer’s disease: from ageing to dementia
Chauveau, L., Landeau, B., Dautricourt, S., Turpin, A., Delarue, M., Hébert, O., Sayette, V. D. L., Chételat, G., & de Florès, R. (2025) · Brain · doi:10.1093/brain/awaf008 · Cited by 31
Moszczynski, A. J., Yang, W., Hammond, R. R., Ang, L. C., & Strong, M. J. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0406-4 · Cited by 30
Modified amyloid variants in pathological subgroups of β‐amyloidosis
Gerth, J., Kumar, S., Upadhaya, A. R., Ghebremedhin, E., Arnim, C. A. F. V., Thal, D. R., & Walter, J. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.577 · Cited by 30
Self-citationToxic Protein Spread in Neurodegeneration: Reality versus Fantasy
Kara, E., Marks, J. D., & Aguzzi, A. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.09.004 · Cited by 30
Retired National Football League Players are Not at Greater Risk for Suicide
Iverson, G. L. (2019) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acz023 · Cited by 30
Amyloid PET in Dementia Syndromes: A Chinese Multicenter Study
Shi, Z., Fu, L., Zhang, N., Zhao, X., Liu, S., Zuo, C., Cai, L., Wang, Y., Gao, S., Ai, L., et al. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.240325 · Cited by 31
Beyond the amyloid cascade: An update of Alzheimer's disease pathophysiology
Gouilly, D., Rafiq, M., Nogueira, L., Salabert, A., Payoux, P., Péran, P., & Pariente, J. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2022.12.006 · Cited by 31
Lachén‐Montes, M., Zelaya, M. V., Segura, V., Fernández‐Irigoyen, J., & Santamaría, E. (2017) · Oncotarget · doi:10.18632/oncotarget.18193 · Cited by 30
Chronic Traumatic Encephalopathy and Neurodegeneration in Contact Sports and American Football
Zuckerman, S. L., Brett, B. L., Jeckell, A. S., Yengo-Kahn, A. M., & Solomon, G. S. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180218 · Cited by 30
Risk of Misdiagnosing Chronic Traumatic Encephalopathy in Men With Depression
Iverson, G. L., & Gardner, A. J. (2019) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.19010021 · Cited by 30
Bachstetter, A. D., Morganti, J. M., Bodnar, C. N., Webster, S. J., Higgins, E. K., Roberts, K. N., Snider, H., Meier, S. E., Nation, G. K., Goulding, D. S., et al. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113180 · Cited by 29
Self-citationMulticenter 18F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer’s Disease
Rullmann, M., Brendel, M., Schroeter, M. L., Saur, D., Levin, J., Perneczky, R. G., Tiepolt, S., Patt, M., Mueller, A., Villemagne, V. L., et al. (2022) · Biomolecules · doi:10.3390/biom12030458 · Cited by 29
Fluid Candidate Biomarkers for Alzheimer’s Disease: A Precision Medicine Approach
Prete, E. D., Beatino, M. F., Campese, N., Giampietri, L., Siciliano, G., Ceravolo, R., & Baldacci, F. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040221 · Cited by 29
Borrego‐Écija, S., Turón‐Sans, J., Ximelis, T., Aldecoa, I., Molina‐Porcel, L., Povedano, M., Rubio, M. Á., Gámez, J., Cano, A., Paré, M., et al. (2021) · Brain Pathology · doi:10.1111/bpa.12942 · Cited by 29
Primary age‐related tauopathy in a Finnish population‐based study of the oldest old (Vantaa 85+)
Savola, S. E., Kaivola, K., Raunio, A., Kero, M., Mäkelä, M., Pärn, K., Palta, P., Tanskanen, M., Tuimala, J., Polvikoski, T. M., et al. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12788 · Cited by 29
Gauthreaux, K. M., Mock, C., Teylan, M., Culhane, J. E., Chen, Y., Chan, K. C. G., Katsumata, Y., Nelson, P. T., & Kukull, W. A. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac093 · Cited by 29
Self-citation
Metadata
- Authors
- Crary, J. F., Trojanowski, J. Q., Schneider, J. A., Abisambra, J. F., Abner, E. L., Alafuzoff, I., Arnold, S. E., Attems, J., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Gearing, M., Grinberg, L. T., Hof, P. R., Hyman, B. T., Jellinger, K., Jicha, G. A., Kovacs, G. G., Knopman, D. S., Kofler, J., Kukull, W. A., Mackenzie, I. R., Masliah, E., McKee, A., Montine, T. J., Murray, M. E., Neltner, J. H., Santa-Maria, I., Seeley, W. W., Serrano-Pozo, A., Shelanski, M. L., Stein, T., Takao, M., Thal, D. R., Toledo, J. B., Troncoso, J. C., Vonsattel, J. P., White, C. L., Wisniewski, T., Woltjer, R. L., Yamada, M., & Nelson, P. T.
- Affiliations
- Columbia University Irving Medical Center (US)
- University of Pennsylvania (US)
- Rush University Medical Center (US)
- University of Kentucky (US)
- Uppsala University (SE)
- Newcastle University (GB)
- Banner Sun Health Research Institute (US)
- Northwestern University (US)
- Washington University in St. Louis (US)
- Mayo Clinic (US)
- Emory University (US)
- Universidade de São Paulo (BR)
- Icahn School of Medicine at Mount Sinai (US)
- Harvard University (US)
- University of Pittsburgh Medical Center (US)
- University of Washington (US)
- University of British Columbia (CA)
- University of California San Diego (US)
- Boston University (US)
- University of California, San Francisco (US)
- Tokyo Metropolitan Geriatric Hospital (JP)
- Universität Ulm (DE)
- The University of Texas Southwestern Medical Center (US)
- Oregon Health & Science University (US)
- Kanazawa University (JP)
- Corresponding author
- Crary, John F.
- Nelson, Peter T.
- ORCID
- Crary, John F.
- Trojanowski, John Q.
- Schneider, Julie A.
- Abisambra, Jose F.
- Abner, Erin L.
- Alafuzoff, Irina
- Arnold, Steven E.
- Attems, Johannes
- Beach, Thomas G.
- Bigio, Eileen H.
- Dickson, Dennis W.
- Gearing, Marla
- Grinberg, Lea T.
- Hof, Patrick R.
- Hyman, Bradley T.
- Jellinger, Kurt
- Jicha, Gregory A.
- Knopman, David S.
- Kofler, Julia
- Kukull, Walter A.
- Mackenzie, Ian R.
- Masliah, Eliezer
- McKee, Ann
- Montine, Thomas J.
- Murray, Melissa E.
- Neltner, Janna H.
- Seeley, William W.
- Shelanski, Michael L.
- Stein, Thor
- Takao, Masaki
- Thal, Dietmar R.
- Troncoso, Juan C.
- White, Charles L.
- Woltjer, Randall L.
- Yamada, Masahito
- Nelson, Peter T.
- Venue
- Acta Neuropathologica
- Published
- 2014-10-28
- Volume
- 128
- Issue
- 6
- Pages
- 755-766
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC4257842
- OpenAlex
- W1971032265
- Cited by
- 1,467
- References
- 160
- Citations by year
- 2026: 85 · 2025: 126 · 2024: 154 · 2023: 123 · 2022: 154 · 2021: 142 · 2020: 143 · 2019: 131 · 2018: 107 · 2017: 119 · 2016: 105 · 2015: 68 · 2014: 9
- FWCI
- 66.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Alzheimer's Association (P30 AG013854, P30AG010124, P01 AG003991, P50 AG025688, P50 AG005681, NIRG-11-204450, P50 AG005136, P50 AG005146)
- BrightFocus Foundation (U01 AG006786, P50 AG016574, P50 AG005136)
- Mayo Foundation for Medical Education and Research (AG016574)
- Alzheimer Forschung Initiative (#13803)
- Alzheimer's Society (AS-PG-2013-011)
- National Institute for Health and Care Research
- Bundesministerium für Bildung und Forschung
- National Institutes of Health (AG028 383, 5r01ag038651-10, AG016574, AG010124, AG005138, AG005133, AG005131, AG008051, AG005681, AG019610, AG003991, AG013854, AG025688, AG003949, AG005136, AG011378)
- Medical Research Council (G0400074, U01 AG006786)
- Japan Society for the Promotion of Science (26430060)
- National Institute on Aging (AG008051, R01‐AG038651, R01AG037212, P30AG028383, P01AG007232, P30AG012300, R37AG018440, P50AG005133, AG184440, U01AG016976, P50AG005131, P50AG005138, U01AG006786, P01AG003949, P30AG010124, AG005131, R01AG011378, P30AG008051, P50AG008702, P50AG005681, P30AG036453, P30AG019610, P50AG005146, P01AG003991, P30AG013846, P50AG005136, P30AG013854, P50AG025688, R01AG041851, P01AG002219, P01AG019724, P50AG016574)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- primary age-related tauopathy, neurofibrillary tangles, tau pathology, Alzheimer's disease, nomenclature, temporal lobe atrophy, tau biomarkers, tau imaging, brain aging, cognitive impairment
- MeSH terms
- Aging, Brain, Diagnosis, Differential, Humans, Terminology as Topic, Tauopathies, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
